Status:
UNKNOWN
Safety and Efficacy of GPOEM in the Treatment of Gastroparesis
Lead Sponsor:
IRCCS San Raffaele
Conditions:
Gastroparesis
Gastroparesis Postoperative
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to assess the clinical efficacy and safety in the treatment of gastroparesis.
Detailed Description
After being informed about the data collected, all the patients affected with gastroparesis undergoing Gastric Per-Oral Endoscopic Myotomy (GPOEM) will be included in the observational protocol. Data...
Eligibility Criteria
Inclusion
- Gastroparesis (GCSI \> 2 OR Gastric emptying half-time \> 180 min OR gastric retention at 120 min \> 60% OR good response to botulinum if former criteria not met)
Exclusion
- Age \< 18 years
- Inability to understand protocol
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04349670
Start Date
June 1 2020
End Date
April 1 2025
Last Update
May 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pier Alberto Testoni
Milan, Italy, 20132